Ann Biomed Eng
Annals of Biomedical Engineering
0090-6964
1521-6047
Kluwer Academic Publishers-Plenum Publishers
New York


1705490
17048104
9190
10.1007/s10439-006-9190-9
Article


Automatic Regulation of Hemodynamic Variables in Acute Heart Failure by a Multiple Adaptive Predictive Controller Based on Neural Networks

Kashihara
Koji

+81-48-462-1111
+81-48-467-6938
kojikasi@mail.goo.ne.jp



RIKEN, Brain Science Institute, 2-1, Hirosawa, Wako-shi, Saitama, 351-0198 Japan 

18
10
2006

12
2006

34
12
1846
1869
16
8
2005

29
8
2006


© Springer Science+Business Media, LLC 2006

NN
NN
NN
−1
−1
−1
−1
NN
NN
NN
 using a simple NN to clinical situations.

Keywords
Cardiac output
Mean arterial pressure
Therapeutic agents
An automated drug infusion system

issue-copyright-statement
© Biomedical Engineering Society 2006




INTRODUCTION
14
12
13
25
3
14

11
21
22
24
28
32
33
11
24
28
5
32
21
22
33
6
7
31
21
22
33
6

15
27
8
17
1
9
NN
NN
NN
 was tested by actual hemodynamics of a canine left heart failure.

MATERIALS AND METHODS
Modeling of Pharmacological Response
NN
Development of Controller
Evaluation of Controller
NN
. In addition, the animal study was divided into two parts. First, to model the pharmacological response in (i), animal experiments were performed using dogs with heart failure. Five of eleven dogs were used for every drug infusion. Then, for additional validation of the developed controller after computer simulations, an animal experiment was performed using one dog with heart failure.
Modeling of Pharmacological Response
the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health
n
 = 5, 26–32 kg) that were anesthetized with pentobarbital sodium and ventilated artificially. A double-lumen catheter was introduced into the right femoral vein for administration of pharmaceutical agents using a computer-controllable infusion pump (CFV-3200; Nihon Kohden, Tokyo, Japan). An in-line electromagnetic flow probe (MFV-2100; Nihon Kohden) was used to measure CO; MAP was measured through a fluid-filled catheter and a pressure transducer (DX-200; Nihon Kohden). The CO and MAP were digitized at a 10-Hz sampling rate through a 12-bit digital-to-analog converter connected to a laboratory computer.
−1
−1
−1
−1
n
−1
−1
n
−1
−1
n
−1
−1
n
n
−1
−1
n
−1
−1
p
−1
−1
−1
−1
1
n
FIGURE 1.
n
left
right
−1
−1
−1
−1
left
right
−1
−1
−1
−1
−1
−1
 was eliminated because of impossible fit to step response.




18
4
30
 The procedure to produce the model responses can be described as follows.
1
−1
−1
−1
−1
ŷ
t
1
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \Delta \mathop y\limits^ \wedge (t) = K\left[ {1 - {\hbox{exp}}\left( { - \frac{{t - L}} {{T_{\rm c} }}} \right)} \right] $$\end{document}

K
L
T
c
t
L
ŷ
t
n
−1
−1
 of a given drug).
y
*
t
2
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \Delta y^* (t) = \sum\limits_{\tau = 0}^{N_{\rm m} } {g(\tau )\Delta Tu(t - \tau )} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ g(\tau ) = \frac{{K_{\rm u} }} {{T_{\rm c} }}\exp \left( { - \frac{{\tau - L}} {{T_{\rm c} }}} \right) $$\end{document}

.
u
t
T
N
m
g
t
K
u
T
c
L
T
N
m
−1
−1
−1
−1
1
−1
−1
1
−1
−1
−1
−1
K
u
T
c
L
g
t
1
left
TABLE 1.
Model parameters in linear-fitting and nonlinear-fitting functions.

Drug-response
Linear
Nonlinefsar

K
u
)
T
c
)
L
)
R
2

p
1
)
p
2
)
R
2



DBT-CO
15.8
164.3
30
0.98
105.3
0.028
0.99

DBT-MAP
4.4
65.2
30
0.75
22.8
0.145
0.98

SNP-CO
3.0
40.6
60
0.28
37.7
0.051
0.80

SNP-MAP
−12.5
209.4
60
0.96
-26.2
−0.085
0.99



K
u
T
c
L
p
1
p
2
K
u
−1
−1
−1
−1
T
c
L
p
1
p
2
R
2
 shows a multiple coefficient of determination.



y
*
t
30
3
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \Delta y'(t) = p_1 \tanh \left( {\frac{{p_2 \Delta y^* (t)}} {2}} \right) $$\end{document}

p
1
y
t
p
2
p
1
p
2
1
right
2
2
−1
−1
−1
−1
1
FIGURE 2.
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
.




4
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \left\{ \begin{aligned}{} & \Delta CO_{\bmod } (t) = a_1  \Delta CO'_1 (t) + a_2  \Delta CO'_2 (t) \\ & \Delta MAP_{\bmod } (t) = b_1  \Delta MAP'_1 (t) + b_2  \Delta MAP'_2 (t) \\ \end{aligned} \right. $$\end{document}

mod
t
1
t
2
t
a
1
a
2
mod
t
1
t
2
t
b
1
b
2
2
a
2
b
2
 can be defined as the strength of the drug interaction when the two treatments for DBT-CO and SNP-MAP loops are performed.

Development of Controller
Control Design
3
NN
NN
FIGURE 3.
NN
r
e
t
e
t
i
) represents the error between the target value and output predicted by the NN. Thick lines show the learning loop in the NN; dotted lines show the prediction loop using the NN.




4
NN
NN
Learning Loop
Prediction Loop
y
NN
mod
mod
y
NN
5
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \Delta y_{{\rm{NN}}} (t) = f\left[ {\Delta y_{{\hbox{mod}}} (t - 1),\,\Delta y_{{\hbox{mod}}} (t - 2),\,u_1 (t - 1),\, \ldots ,\,u_1 (t - 6),\,u_2 (t - 1),\, \ldots ,\,u_2 (t - 6)} \right] $$\end{document}

y
mod
t
y
mod
t
u
1
t
u
1
t
u
2
t
u
2
t
Learning of Initial Weights in NN
4
mod
NN
left
mod
NN
right
a
1
a
2
b
1
b
2
m
n
1
n
2
m
n
1
n
2
K
n
1
K
n
2
4
4
FIGURE 4.
NN
mod
NN
left
mod
NN
right
a
1
a
2
b
1
b
2
left
right
).




m
n
1
n
2
4
A). The two NN for the controls of DBT-CO and SNP-MAP loops had identical structures.
mod
mod
NN
6
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \left\{ \begin{aligned}{} & J_1 (t) = q_1 \left[ {u_1 (t) - u_1 (t - 1)} \right]^2 + \sum\limits_{i = 1}^{N_{p1} } {\left[ {r_1 (t + i) - \Delta {\hbox{CO}}_{{\rm{NN}}} (t + i)} \right]^2 } \\ & J_2 (t) = q_2 \left[ {u_2 (t) - u_2 (t - 1)} \right]^2 + \sum\limits_{i = 1}^{N_{p2} } {\left[ {r_2 (t + i) - \Delta {\hbox{MAP}}_{{\rm{NN}}} (t + i)} \right]^2 } \\ \end{aligned} \right. $$\end{document}


J
1
t
J
2
t
q
1
q
2
N
p
1
N
p
2
r
1
r
2
NN
NN
u
1
t
u
2
t
16
27


Determination of Control Parameters
Learning of Initial Weights in NN
mod
mod
NN
−1
−1
9
27
mod
mod
mod
mod
 was divided by 100 for normalization during NN learning.
4
mod
NN
left
mod
NN
right
a
1
a
2
b
1
b
2
K
n
1
K
n
2
mod
mod
−1
−1
 in the DBT-CO loop and 1.5 mmHg in the SNP-MAP loop.

Controller Tuning
N
p
1
N
p
2
q
1
q
2
mod
mod
N
p
1
N
p
2
q
1
q
2
mod
mod
K
n
1
K
n
2
r
1
t
−1
−1
r
1
−1
−1
r
2
 = ±0 mmHg. The duration of the closed-loop control was set to 40 min.
5
NN
mod
mod
a
1
a
2
b
1
b
2
q
1
= q
2
N
p
1
N
p
2
q
1
= q
2
N
p
1
N
p
2
q
1
= q
2
N
p
1
N
p
2
N
p
1
N
p
2
q
1
q
2
NN
N
p
1
N
p
2
q
1
q
2
−1
−1
mod
mod
mod
mod
−1
−1
FIGURE 5.
NN
mod
mod
a
1
= a
2
= b
1
= b
2
=
q
1
q
2
N
p
1
N
p
2
K
n
1
K
n
2
 = 0.2 under all conditions.







Evaluation of Controller
Simulations
NN
22
30
−1
−1
6
7
−1
−1
1
−1
−1
t
1
u
1
t
u
2
t
5
22
 Hemodynamic control was simulated under the following cases: drug interactions between DBT and SNP, acute disturbances, and time-variant changes of physiological parameters.
Drug Interactions
6
30
a
1
a
2
b
1
b
2
6
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
FIGURE 6.
NN
a
1
a
2
b
1
b
2
mod
mod
 (solid lines), and predicted outputs by NN (dashed lines). B(b) and C(b) are the time courses of weights changed from the baseline at the starting time in the NN for controllers in the DBT-CO and SNP-MAP loops: weights between input and first hidden layers (top), first and second hidden layers (middle), and second hidden and output layers (bottom). D. Infusion rates of DBT (solid line) and SNP (dashed line).




NN
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
 = 5 or 10) sensitivities to drugs and drug interactions. The limitations of infusion rates of drugs were eliminated to emphasize the control performance. The control duration was 40 min.

Acute Disturbances
10
20
NN
mod
mod
−1
−1
mod
mod
−1
−1
mod
mod
9
A(a) and B(a)].
NN
−1
−1
mod
mod
−1
−1
−1
−1
a
1
a
2
b
1
b
2
10
NN
−1
−1
mod
mod
−1
−1
−1
−1
a
1
a
2
b
1
b
2
11
NN
a
1
a
2
b
1
b
2
−1
−1
mod
mod
11
B). In those simulations, the limitations of infusion rates of drugs were eliminated to elucidate the limitations of the control performance.

Time-variant Changes
2
26
30
L
12
a
1
a
2
b
1
b
2
12
−1
−1
mod
mod.
−1
−1
mod
mod
12
B(a) and C(a)]. The control duration was 120 min.


Animal Study
NN
 under the unknown physiological responses such as nonlinearity and drug interaction, the simultaneous control of CO and MAP was performed using a dog with acute heart failure. Acute ischemic heart failure in an anesthetized and ventilated dog (23 kg) was induced by microsphere embolization of the left main coronary artery. A double-lumen catheter was introduced into the right femoral vein for administration of drugs using an infusion pump (CFV-3200; Nihon Kohden, Tokyo, Japan). CO was measured by an electromagnetic flow probe (MFV-2100; Nihon Kohden), and MAP was measured through a pressure transducer (DX-200; Nihon Kohden) at a 10-Hz sampling rate through a 12-bit digital-to-analog converter.
−1
−1
u
1
t
u
2
t
) ≤ 6 in SNP.



RESULTS
Simulations
Drug Interactions
6
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
−1
−1
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
−1
−1
−1
−1
6
B(b) and C(b)] when the unexpected changes occurred. The infusion rates of DBT and SNP were adjusted smoothly to optimal levels corresponding to the unknown patient responses to drugs.
2
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
a
1
a
1
7
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
TABLE 2.
Average errors between setpoints and model responses in CO and MAP under various sensitvities to drugs and drug interactions.

a
1
):
Low
Mid.
High

a
2
):










b
1
)
b
2
)
Low
Mid.
High
Low
Mid.
High
Low
Mid.
High


Low
Low
5.5 (0.5)
4.8 (0.4)
3.4 (0.3)
2.9 (0.3)
2.7 (0.3)
2.2 (0.2)
1.3 (0.1)
1.2 (0.1)
1.2 (0.1)

Mid.
5.3 (10.3)
4.1 (4.8)
3.0 (1.0)
3.3 (1.9)
2.6 (1.0)
2.0 (0.7)
1.3 (0.5)
1.2 (0.5)
1.2 (0.4)

High
5.7 (45.0*)
3.8 (25.1*)
4.2 (3.0)
3.5 (17.3)
2.9 (6.1)
2.2 (1.6)
4.2 (3.4)
3.9 (3.5)
1.5 (1.2)

Mid.
Low
6.0 (1.2)
5.7 (1.2)
5.8 (1.1)
3.2 (0.6)
2.9 (0.6)
2.4 (0.5)
1.5 (0.4)
1.4 (0.4)
1.3 (0.3)

Mid.
5.5 (0.6)
4.7 (0.5)
3.5 (0.4)
3.2 (0.5)
2.8 (0.5)
2.1 (0.4)
1.6 (0.4)
1.4 (0.4)
1.3 (0.3)

High
5.3 (29.6*)
3.8 (12.2)
3.4 (1.9)
3.3 (3.9)
2.7 (1.4)
2.0 (1.0)
1.9 (1.1)
1.7 (0.9)
1.3 (0.7)

High
Low
6.0 (2.5)
5.9 (2.5)
6.2 (2.3)
2.8 (0.7)
2.8 (0.6)
2.7 (0.7)
1.3 (0.6)
1.3 (0.5)
1.3 (0.4)

Mid.
6.0 (4.1)
6.2 (3.9)
7.0 (3.4)
2.9 (0.6)
2.8 (0.6)
2.5 (0.6)
1.4 (0.6)
1.3 (0.5)
1.3 (0.4)

High
5.6 (1.0)
4.8 (0.7)
6.4 (4.3)
3.2 (0.8)
2.9 (0.8)
2.3 (1.3)
2.0 (1.6)
1.8 (1.6)
1.5 (1.5)



7
).


FIGURE 7.
NN
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
top
middle
bottom
left
right
).




NN
7
−1
−1
, irrespective of the remaining the hypertension.
8
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
−1
−1
a
1
8
left
−1
−1
a
1
a
2
b
1
b
2
−1
−1
a
1
a
2
b
1
b
2
8
NN
FIGURE 8.
NN
a
1
a
2
b
1
b
2
a
1
a
2
b
1
b
2
top
middle
bottom
left
right
). The limitations of drug infusion rates were eliminated.





Acute Disturbances
9
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
−1
−1
−1
−1
a
1
a
2
b
1
b
2
mod
mod
−1
−1
mod
NN
−1
−1
9
FIGURE 9.
NN
mod
mod
mod
mod
 (solid lines), and predicted outputs by NNs (dashed lines). A(c) and B(c) indicate weight changes in NN for the controllers in DBT-CO and SNP-MAP loops: weights between the input and first hidden layers (top), first and second hidden layers (middle), and second hidden and output layers (bottom). C. Infusion rates of DBT (solid line) and SNP (dashed line).




10
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
mod
mod
10
a
1
a
2
b
1
b
2
10
FIGURE 10.
NN
mod
mod
mod
mod
−1
−1 
−1
−1 
mod
mod
a
1
a
2
b
1
b
2
 = 1). A(c) and B(c) indicate the error between the model response and the predicted response by NN during control. A(d) and B(d) are Infusion rates of DBT and SNP. The limitations of drug infusion rates were eliminated.




11
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
−1
−1
mod
mod
−1
−1
−1
−1
a
1
a
2
b
1
b
2
FIGURE 11.
NN
−1
−1
mod
mod
−1
−1
−1
−1
−1
−1
a
1
a
2
b
1
b
2
top
middle
bottom
left
right
). The limitations of drug infusion rates were eliminated.




11
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
−1
−1
a
1
a
2
b
1
b
2
−1
−1
b
1
 = 3). However, the infusion rate of SNP was adjusted to the optimal value at approximately 70 min.

Time-variant Changes
12
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
−1
−1
−1
−1
−1
−1
−1
−1
12
FIGURE 12.
NN
L
a
1
a
2
b
1
b
2
mod
mod
mod
mod
 (solid lines), and predicted outputs by NN (dashed lines). B(c) and C(c) are the weight changes in NN for controllers in DBT-CO and SNP-MAP loops: weights between input and first hidden layers (top), first and second hidden layers (middle), and second hidden and output layers (bottom). D. Infusion rates of DBT (solid line) and SNP (dashed line).






Animal Study
13
NN
N
p
1
N
p
2
q
1
q
2
K
n
1
K
n
2
NN
−1
−1
FIGURE 13.
NN
 under canine left heart failure. Raw data of CO (top) and MAP (middle) responses during DBT and SNP infusions. Bottom in the graph is the Infusion rates of DBT (solid line) and SNP (dashed line).






DISCUSSION
NN
6
9
12
13
) because of its ability to learn nonlinear and time-variant changes of the system during the on-line control.
1
14
β
1
β
2
30
1
6
6
9
12
13
NN
12
13
25

NN
6
9
12
13
6
NN
7
10
NN
9
12
2
26
NN
12
NN
13
6
9
12
).
3
21
5
. A controller based on NN solves those problems because it decreases the number of models required for the control design of the various changes of hemodynamics clearly.
2
14
NN
NN
6
9
12
13
NN
9
1
22
29
NN
 tested herein can be extended simply to multivariate control systems under such clinical conditions for drug therapy with heart failure.
NN
7
8
10
11
NN
8
11
NN
7
8
11
b
2
b
1
7
NN
 was actually incapable of attenuating the induced hypertension. Those cases resulted from nonlinear model responses to drugs in the present study; the hemodynamic responses, therefore, would have saturated because of the range of nonlinear model responses, regardless of the increase of drug infusion rates.
NN
NN
7
7
11
NN
a
1
8
11
NN
NN
 would fall into a situation of control impossibility. Second, the physiological variations related with responses to anesthesia, antiarrhythmic drug, and muscle relaxant, the external disturbances, and the artificial background noise must be set to the smallest possible values to bring out the best performance of the controller.
Modeling of Pharmacological Response
19
) has a slower response than that of an electromagnetic probe. The high accuracy of a flow probe, such as the time resolution (at least 30 s as used for this experiment), and the pure time delay from an actual response (as few response delays as possible) would be required to acquire the results that were obtained in the present study.

CONCLUSIONS
NN
NN
2
) and actual response of a dog in heart failure. Flexibility of a NN coupled with an adaptive control mechanism will enable the regulation of various physiological responses to drugs with heart failures.


Acknowledgment
The animal study was supported by the National Cardiovascular Center Research Institute (2001.10–2004.3).

APPENDIX
23
E
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ {\rm E} = \frac{1} {2}  \varepsilon ^2 = \frac{1} {2}  \left( {\Delta y_{{\rm{mod}}} - \Delta y_{{\rm{NN}}} } \right)^2 $$\end{document}

y
mod
y
NN
y
mod
ε
y
mod
y
NN
E
9
27
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ w^* = w + K_{\rm{n}} \Delta w $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$ \Delta w = \frac{{\partial E}} {{\partial w}} = \frac{{\partial E}} {{\partial \varepsilon }}\frac{{\partial \varepsilon }} {{\partial y_{NN} }}\frac{{\partial y_{{\rm{NN}}} }} {{\partial w}} = - \varepsilon \frac{{\partial y_{{\rm{NN}}} }} {{\partial w}} $$\end{document}

w*
w
w
K
n

K
n
1
K
n
2
9



REFERENCES
1.
Chen
C. T.

Lin
W. L.

Kuo
T. S.

Wang
C. Y.


Adaptive control of arterial blood pressure with a learning controller based on multilayer neural networks
IEEE Trans. Biomed. Eng.
1997
44
601
609
10.1109/10.594901

9210820


2.
Delapasse
J. S.

Behbehani
K.

Tsui
K.

Klein
K. W.


Accommodation of time delay variations in automatic infusion of sodium nitroprusside
IEEE Trans. Biomed. Eng.
1994
41
1083
1091
10.1109/10.335846

8001997


3.
Forrester
J. S.

Diamond
G.

Chatterjee
K.

Swan
H. J.


Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts)
N Engl. J. Med.
1976
295
1404
1413

790194


4.
Gingrich
K. J.

Roy
R. J.


Modeling the hemodynamic response to dopamine in acute heart failure
IEEE Trans. Biomed. Eng.
1991
38
267
272
10.1109/10.133208

2066140


5.
Gopinath
R.

Bequette
B. W.

Roy
R. J.

Kaufman
H.

Yu
C.


Issues in the design of a multirate model-based controller for a nonlinear drug infusion system
Biotechnol. Prog.
1995
11
318
332
10.1021/bp00033a013

7619401


6.
Held
C. M.

Roy
R. J.


Multiple drug hemodynamic control by means of a supervisory-fuzzy rule-based adaptive control system: Validation on a model
IEEE Trans. Biomed. Eng.
1995
42
371
385
10.1109/10.376130

7729836


7.
Huang
J. W.

Roy
R. J.


Multiple-drug hemodynamic control using fuzzy decision theory
IEEE Trans. Biomed. Eng.
1998
45
213
228
10.1109/10.661269

9473844


8.
Isaka
S.

Sebald
A. V.


Control strategies for arterial blood pressure regulation
IEEE Trans. Biomed. Eng.
1993
40
353
363
10.1109/10.222328

8375872


9.
Kashihara
K.

Kawada
T.

Uemura
K.

Sugimachi
M.

Sunagawa
K.


Adaptive predictive control of arterial blood pressure based on a neural network during acute hypotension
Ann. Biomed. Eng.
2004
32
1365
1383
10.1114/B:ABME.0000042225.19806.34

15535055


10.
Martin
J. F.

Smith
N. T.

Quinn
M. L.

Schneider
A. M.


Supervisory adaptive control of arterial pressure during cardiac surgery
IEEE Trans. Biomed. Eng.
1992
39
389
393
10.1109/10.126611

1592404


11.
McInnis
B. C.

Deng
L. Z.


Automatic control of blood pressures with multiple drug inputs
Ann. Biomed. Eng.
1985
13
217
225

4037454


12.
Meretoja
O. A.


Influence of sodium nitroprusside and dobutamine on the haemodynamic effects produced by each other
Acta Anaesthesiol. Scand.
1980
24
195
198

7445937


13.
Miller
R. R.

Awan
N. A.

Joye
J. A.

Maxwell
K. S.

DeMaria
A. N.

Amsterdam
E. A.

Mason
D. T.


Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction
Circulation
1977
55
881
884

858184


14.
Mohrman
D. E.

Heller
L. J.


Cardiovascular physiology
1997
4
New York
McGraw-Hill

Mohrman D. E., L. J. Heller, (1997) Cardiovascular physiology, 4th ed. New York: McGraw-Hill 

15.
Narendra
K. S.

Parthasarathy
K.


Identification and control of dynamic systems using neural networks
IEEE Trans. Neural Netw.
1990
1
4
27
10.1109/72.80202

18282820


16.
Nelder
J. A.

Mead
R.


A simplex method for function minimization
Comput. J.
1965
7
308
313

Nelder J. A., R. Mead (1965) A simplex method for function minimization. Comput. J. 7:308–313 

17.
O’Hara
D. A.

Bogen
D. K.

Noordergraaf
A.


The use of computers for controlling the delivery of anesthesia
Anesthesiology
1992
77
563
581

1519793


18.
Parker
R. S.

Doyle
F. J.


Control-relevant modeling in drug delivery
Adv. Drug Deliv. Rev.
2001
48
211
228
10.1016/S0169-409X(01)00114-4

11369083


19.
Pinsky
M. R.


Why measure cardiac output?
Crit. Care.
2003
7
2
114
116
10.1186/cc1863

12720554


20.
Quinn
M. L.

Smith
N. T.

Mandel
J. E.

Martin
J. F.

Schneider
A. M.


Automatic control of arterial pressure in the operating room: Safety during episodes of artifact and hypotension?
Anesthesiology
1988
68
A327

Quinn M. L., N. T. Smith, J. E. Mandel, J. F. Martin, A. M. Schneider (1988) Automatic control of arterial pressure in the operating room: Safety during episodes of artifact and hypotension? Anesthesiology 68:A327 

21.
Rao
R. R.

Aufderheide
B.

Bequette
B. W.


Experimental studies on multiple-model predictive control for automated regulation of hemodynamic variables
IEEE Trans. Biomed. Eng.
2003
50
277
288
10.1109/TBME.2003.808813

12669984


22.
Rao
R. R.

Bequette
B. W.

Roy
R. J.


Simultaneous regulation of hemodynamic and anesthetic states: A simulation study
Ann. Biomed. Eng.
2000
28
71
84
10.1114/1.255

10645790


23.
Rumelhart D. E., G. E. Hinton, R. J. Williams. Learning internal representations by error propagation. In: J. L. McClelland, D. E. Rumelhart, and The PDP research group (eds), Parallel Distributed Processing. Vol. 1, MIT Press, Cambridge, MA, 1986

24.
Serna V., R. Roy, H. Kaufman. Adaptive control of multiple drug infusions. Presented at the Am. Contr. Conf., San Francisco, CA, 1983, pp. 22–24

25.
Stemple
D. R.

Kleiman
J. H.

Harrison
D. C.


Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions
Am. J. Cardiol.
1978
42
267
275
10.1016/0002-9149(78)90909-8

685839


26.
Stern
K. S.

Chizeck
H. J.

Walker
B. K.

Krishnaprasad
P. S.

Dauchot
P. J.

Katona
P. G.


The self-tuning controller: Comparison with human performance in the control of arterial pressure
Ann. Biomed. Eng.
1985
13
341
357
10.1007/BF02407765

4073623


27.
Takahashi
Y.


Adaptive predictive control of nonlinear time-varying system using neural network
IEEE Int. Conf. Neural Netw.
1993
3
1464
1468

Takahashi Y. (1993) Adaptive predictive control of nonlinear time-varying system using neural network. IEEE Int. Conf. Neural Netw. 3:1464–1468 

28.
Voss
G. I.

Katona
P. G.

Chizeck
H. J.


Adaptive multivariable drug delivery: Control of arterial pressure and cardiac output in anesthetized dogs
IEEE Trans. Biomed. Eng.
1987
34
617
623

3623588


29.
Westenskow
D. R.


Automating patient care with closed-loop control
MD Comput.
1986
3
14
20

3574027


30.
Woodruff
E. A.

Martin
J. F.

Omens
M.


A model for the design and evaluation of algorithms for closed-loop cardiovascular therapy
IEEE Trans. Biomed. Eng.
1997
44
694
705
10.1109/10.605426

9254983


31.
Ying
H.

McEachern
M.

Eddleman
D. W.

Sheppard
L. C.


Fuzzy control of mean arterial pressure in postsurgical patients with sodium nitroprusside infusion
IEEE Trans. Biomed. Eng.
1992
39
1060
1070
10.1109/10.161338

1452172


32.
Yu
C.

Roy
R. J.

Kaufman
H.


A circulatory model for combined nitroprusside-dopamine therapy in acute heart failure
Med. Prog. Technol.
1990
16
77
88

2138700


33.
Yu
C.

Roy
R. J.

Kaufman
H.

Bequette
B. W.


Multiple-model adaptive predictive control of mean arterial pressure and cardiac output
IEEE Trans. Biomed. Eng.
1992
39
765
778
10.1109/10.148385

1505992





